Log In
Print
BCIQ
Print
Print this Print this
 

Biosimilar fabrazyme (ISU303)

  Manage Alerts
Collapse Summary General Information
Company Isu Abxis Co. Ltd.
DescriptionFabrazyme biosimilar
Molecular Target
Mechanism of ActionEnzyme replacement therapy
Latest Stage of DevelopmentPhase II
IndicationFabry's disease
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today